Research Areas

In Clinic Evaluation of the FreeStyle Navigator Continuous Glucose Monitoring System Version 1.5

An Investigational Blood Glucose Monitoring System Lay User and Professional Clinical Accuracy, Labeling Comprehension, Human Factors, and AST Regulatory Study

Patient Reporting of Type 2 Diabetes Symptoms using a glucose meter

Observational Study to Assess Frailty of Subjects During Two Previous Zoster Vaccine Studies.

Efficacy and Long-Term Safety of An Investigational Oral Medication Versus Sitagliptin in Subjects With Type 2 Diabetes.

A 24-Week, Multicenter, Randomized, Open-Label, Parallel-Group Study Comparing the Efficacy and Safety of Two Marketed and Approved Insulins in Insulin-Naïve Patients with Type 2 Diabetes Mellitus not Adequately Controlled with Oral Antidiabetic Drug(s) ± GLP-1 receptor agonist

Flexible Dose Adjustment. Efficacy and Safety of an Investigational Oral GLP-1 Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects with Type 2 Diabetes Mellitus

A Phase 2, Double Blind, Placebo Controlled, 18 Week Trial of Investigational GLP-1 Doses Versus Placebo in Patients with Type 2 Diabetes on Metformin Monotherapy

Dynamic Responsiveness of Insulin Secretory Parameters to Sitagliptin and Glimepiride Administration in Subjects with Type 2 Diabetes Mellitus: An Open Label Study

A Prospective, Randomized, Double-Blind Comparison of An Investigational Insulin to Insulin Lispro, Both in Combination with Insulin Glargine or Insulin Degludec in Adults with Type 2 Diabetes

Six Month, Randomized, Open Label, Parallel Group Comparison of An Investigational Insulin to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine, With a 6-Month Safety Extension Period

An Open Label, Randomized, Multicenter, Phase III Study Compare the Immunogenicity, Efficacy, And Safety of A Biosimilar Insulin Glargine Injection to Lantus (Insulin Glargine Injection) In Adult Subjects with Type 2 Diabetes Mellitus

A Randomized, Double Blind, Placebo Controlled, 3-Arm, Parallel Group, 52-Week Multicenter Study to Evaluate the Efficacy and Safety of An Investigational Medication in Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a single and Repeated Subcutaneous Doses of An Investigational Medication in Subjects with Type 2 Diabetes Mellitus

A Randomized, Active-Controlled, Parallel Group, 16-Week Open Label Study Comparing the Efficacy And Safety Of The Morning Injection Of An Approved Basal Insulin Versus Lantus In Patients With Type 1 Diabetes Mellitus.

A Phase 2b, Multicenter, Randomized, Double Blind, Titration Clinical Trial Evaluating the Efficacy and Safety of An Investigational Insulin Lispro in Combination with a Basal Insulin Versus Insulin Lispro in Combination with a Basal Insulin (Insulin Lispro, the Control Group), in Patients with Type 1 Diabetes Mellitus Over a 26-week Treatment Period.

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of An Investigational FastActing Insulin compared to NovoRapid in Adults with Type 1 Diabetes.

An Investigational Glucagon Injection Compared to A Marketed Glucagon for Induced Hypoglycemia Rescue in Adult Patients with T1D. A Phase 3, Randomized, Blinded, 2-Way Crossover Study to Evaluate Efficacy and Safety

Study Comparing Prandial Insulin Aspart vs Technosphere Insulin in Patients with Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real Life Pilot Study

A Prospective, Randomized, Double Blind Comparison of An Investigational Insulin to Insulin Lispro With An Open-Label Postprandial Investigational Insulin Treatment Group in Combination with Insulin Glargine or Insulin Degludec in Adults with Type 1 Diabetes